Fierce Biotech
Pfizer beats out Novo with $10B agreement to buy Metsera
After a chaotic and fierce bidding clash that only burst out into public view a little more than a week ago, Pfizer has prevailed in its pursuit of obesity biotech Metsera. | After a chaotic and fierce bidding clash that only burst out into public view a little more than a week ago, Pfizer has prev…
